5701 - 5725 of 8471 Results
Title
Year
-
RESTRICTEDTitle: Artificial Neural Network–Based Prediction of Outcome in Parkinson’s Disease Patients Using DaTscan SPECT Imaging FeaturesJournal Name: Molecular Imaging and BiologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 6Start Page: 1165End Page: 1173Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11307-019-01334-5Citation Count: 42
-
OPENTitle: Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesisJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-08858-yBest OA location URL: https://www.nature.com/articles/s41467-019-08858-y.pdfCitation Count: 266
-
OPENTitle: M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress DisorderJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 989End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2019.02.020Best OA location URL: https://europepmc.org/articles/pmc6555658?pdf=renderCitation Count: 33
-
OPENTitle: Comparative study of cerebrospinal fluid α‐synuclein seeding aggregation assays for diagnosis of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 4Start Page: 536End Page: 544Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27646Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27646Citation Count: 193
-
OPENTitle: Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegenerationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 116Issue #: 12Start Page: 5765End Page: 5774Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1814909116Best OA location URL: https://www.pnas.org/content/pnas/116/12/5765.full.pdfCitation Count: 98
-
OPENTitle: Predictive model of spread of Parkinson's pathology using network diffusionJournal Name: NeuroImagePublisher: Elsevier BVVol: 192Issue #:Start Page: 178End Page: 194Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.neuroimage.2019.03.001Best OA location URL: https://doi.org/10.1016/j.neuroimage.2019.03.001Citation Count: 73
-
OPENTitle: Reduced habit-driven errors in Parkinson’s DiseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-39294-zBest OA location URL: https://www.nature.com/articles/s41598-019-39294-z.pdfCitation Count: 12
-
RESTRICTEDTitle: Interrogating the Genetic Determinants of Tourette’s Syndrome and Other Tic Disorders Through Genome-Wide Association StudiesJournal Name: American Journal of PsychiatryPublisher: American Psychiatric Association PublishingVol: 176Issue #: 3Start Page: 217End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1176/appi.ajp.2018.18070857Best OA location URL: https://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.2018.18070857Citation Count: 252
-
OPENTitle: Prioritizing Parkinson’s disease genes using population-scale transcriptomic dataJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-08912-9Best OA location URL: https://www.nature.com/articles/s41467-019-08912-9.pdfCitation Count: 154
-
RESTRICTEDTitle: Real-World Experience With VMAT2 InhibitorsJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 42Issue #: 2Start Page: 37End Page: 41Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000326Citation Count: 43
-
OPENTitle: An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 alleleJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 127Issue #:Start Page: 278End Page: 286Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2019.02.023Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6588475Citation Count: 26
-
RESTRICTEDTitle: Memory impairment in Parkinson’s disease: The retrieval versus associative deficit hypothesis revisited and reconciled.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 33Issue #: 3Start Page: 391End Page: 405Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/neu0000503Citation Count: 30
-
OPENTitle: Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathwaysJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-019-0675-9Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-019-0675-9Citation Count: 16
-
OPENTitle: Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)Journal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 266Issue #: 5Start Page: 1203End Page: 1210Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-019-09250-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-019-09250-y.pdfCitation Count: 17
-
OPENTitle: Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 2Start Page: 301End Page: 313Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-191576Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191576?id=journal-of-parkinsons-disease%2Fjpd191576Citation Count: 114
-
OPENTitle: LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic miceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-019-0679-5Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-019-0679-5Citation Count: 45
-
OPENTitle: Magnetic resonance imaging–guided phase 1 trial of putaminal AADC gene therapy for Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 5Start Page: 704End Page: 714Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25450Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25450Citation Count: 132
-
RESTRICTEDTitle: A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystoniaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 195End Page: 198Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.035Citation Count: 25
-
RESTRICTEDTitle: Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T CellsJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2019.00303Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2019.00303/pdfCitation Count: 121
-
RESTRICTEDTitle: Dual threshold neural closed loop deep brain stimulation in Parkinson disease patientsJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 4Start Page: 868End Page: 876Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2019.02.020Citation Count: 223
-
RESTRICTEDTitle: Targeting the Iron-Response Elements of the mRNAs for the Alzheimer’s Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese NeurotoxicityJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 20Issue #: 4Start Page: 994End Page: 994Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms20040994Best OA location URL: https://www.mdpi.com/1422-0067/20/4/994/pdf?version=1551081390Citation Count: 19
-
OPENTitle: Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activityJournal Name: Molecular MetabolismPublisher: Elsevier BVVol: 24Issue #:Start Page: 120End Page: 138Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.molmet.2019.02.005Best OA location URL: https://doi.org/10.1016/j.molmet.2019.02.005Citation Count: 11
-
OPENTitle: The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 163End Page: 169Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.027Best OA location URL: http://spiral.imperial.ac.uk/bitstream/10044/1/68972/2/WilsonPolitis_PDE4_SleepPD_RevisedText_Clean.pdfCitation Count: 15
-
RESTRICTEDTitle: Correction to Conversion of Quinazoline Modulators from Inhibitors to Activators of β-GlucocerebrosidaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 62Issue #: 5Start Page: 2850End Page: 2850Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.9b00284Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b00284Citation Count: 0
-
OPENTitle: Network abnormalities among non‐manifesting Parkinson disease related LRRK2 mutation carriersJournal Name: Human Brain MappingPublisher: WileyVol: 40Issue #: 8Start Page: 2546End Page: 2555Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.24543Best OA location URL: https://europepmc.org/articles/pmc6865680?pdf=renderCitation Count: 21